- Home
- LAES vs ALT Comparison
LAES vs ALT Comparison
Compare LAES & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- ALT
- Stock Information
- Founded
- LAES 2022
- ALT 1997
- Country
- LAES Switzerland
- ALT United States
- Employees
- LAES N/A
- ALT N/A
- Industry
- LAES Semiconductors
- ALT Biotechnology: Pharmaceutical Preparations
- Sector
- LAES Technology
- ALT Health Care
- Exchange
- LAES Nasdaq
- ALT Nasdaq
- Market Cap
- LAES 483.1M
- ALT 529.9M
- IPO Year
- LAES N/A
- ALT N/A
- Fundamental
- Price
- LAES $4.24
- ALT $6.86
- Analyst Decision
- LAES Strong Buy
- ALT Strong Buy
- Analyst Count
- LAES 1
- ALT 8
- Target Price
- LAES $1.75
- ALT $19.71
- AVG Volume (30 Days)
- LAES 80.8M
- ALT 2.7M
- Earning Date
- LAES 09-25-2024
- ALT 11-12-2024
- Dividend Yield
- LAES N/A
- ALT N/A
- EPS Growth
- LAES N/A
- ALT N/A
- EPS
- LAES N/A
- ALT N/A
- Revenue
- LAES $20,135,000.00
- ALT $52,000.00
- Revenue This Year
- LAES N/A
- ALT N/A
- Revenue Next Year
- LAES N/A
- ALT N/A
- P/E Ratio
- LAES N/A
- ALT N/A
- Revenue Growth
- LAES N/A
- ALT N/A
- 52 Week Low
- LAES $0.29
- ALT $5.28
- 52 Week High
- LAES $11.00
- ALT $14.84
- Technical
- Relative Strength Index (RSI)
- LAES 48.81
- ALT 41.92
- Support Level
- LAES $4.04
- ALT $6.19
- Resistance Level
- LAES $5.25
- ALT $7.83
- Average True Range (ATR)
- LAES 1.71
- ALT 0.41
- MACD
- LAES -0.52
- ALT -0.06
- Stochastic Oscillator
- LAES 15.92
- ALT 36.41
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. Its vaultIC range offers a complete set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.